David Rind
Physician and health economist serving as chief medical officer at the Institute for Clinical and Economic Review (ICER), known for leading evidence and value assessments of medical technologies and drugs.
Best podcasts with David Rind
Ranked by the Snipd community
Feb 5, 2026 • 51min
#62: GLP-1s: Life-Changing Results… at What Cost?
Dr. David Rind, physician and health economist who leads value assessments at ICER. He and Bobby dig into how GLP-1s like semaglutide and tirzepatide change appetite and drive large weight loss. They cover cardiovascular and metabolic effects, GI side effects and muscle loss, high real-world discontinuation, and the big question of how to pay for widespread use without breaking budgets.
